Improving Medication Safety for Kidney Disease with a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.

Not yet recruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 1, 2026

Conditions
Chronic Kidney Disease Stage 4Chronic Kidney Disease Stage 5
Interventions
OTHER

Electronic Drug Dosing and Decision Support Kidney (eDoseCKD) Tool

Thirty evidence, expert informed and validated computerized drug decision support algorithms of high risk medications will be utilized by community pharmacists for individuals with an eGFR \< 60 ml/min who are on one of the 30 target algorithms. The will be followed up to 3 months to assess effectivess, safety and whether the dose change was maintained.

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT06820372 - Improving Medication Safety for Kidney Disease with a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice. | Biotech Hunter | Biotech Hunter